Ruben Pellicer-Guridi | Biomedical engineering | Best Researcher Award

Posted on by ScienceFather

Dr. Ruben Pellicer-Guridi |  Biomedical engineering | Best Researcher Award

Postdoc at Asociacion de Investigacion MPC, Spain

🌍 Passionate physicist advancing affordable MRI and NMR technologies using innovative quantum sensing with NV centers in diamond. 📍Based in Spain, drives impactful projects for health, environment, and food sectors through groundbreaking research and entrepreneurial ventures. 🌟 Award-winning expert with a strong focus on real-world applications.

 

Publication Profile

orcid

scopus

Education🎓 

Ph.D. in Magnetic Resonance Imaging, University of Queensland, Australia (2014–2019) Internship & Research Assistant, ETH Zurich, Switzerland (2011)  Associate Fellow, Higher Education Academy (AFHEA) for teaching excellence.  Built expertise in magnetic resonance instrumentation and quantitative imaging across leading European institutions.

Experience💡 

PostDoc Fellow, Quantum Nanophotonics Lab, Spain (2021–present): Revolutionizing quantum-based NMR.  Principal Investigator, I3M Valencia (2020–2021): Developed cost-effective, portable MRI prototypes.  Visiting Academic, Charité Berlin (2020): Enhanced hyperthermia devices for cancer treatment. Ph.D. Candidate & Fellow, University of Queensland (2014–2019): Advanced low-field MRI methods with groundbreaking patents.

Awards & Honors🏆

2022 Spin-Off Award, Valencian Community: Portable MRI innovation. BioMedTech Horizons Grant ($1M AUD): For low-field MRI development. Marie Skłodowska-Curie MSCA Fellowship: Quantum sensing for NMR systems.  Recognized by prestigious European institutions for pioneering affordable, cutting-edge MRI systems.

Research Focus🔬

Quantum NMR methods with NV centers for next-gen sensing.  Low-field portable MRI for affordable diagnostics.  RF antenna development for optimized electron spin control.  Bridging high-tech innovation with real-world medical, environmental, and societal needs.

 

Publication  Top Notes

Quantum-inspired Clustering with Light: Explores clustering methods inspired by quantum computing, applying light-based technologies. Published in Scientific Reports (2024).

Open-source MRI: Highlights the benefits of open-source MRI technology for improving global access, science, and education. Published in NMR in Biomedicine (2024).

Machine Learning for Magnetometry: Discusses automatic optimization of nitrogen vacancy center-based magnetometry using machine learning, presented at the Optica Sensing Congress 2024.

MaRCoS System for Low-field MRI: Focuses on MaRCoS, an open-source electronic control system for low-field MRI. Published in Journal of Magnetic Resonance (2023).

Benchmarking Low-cost MRI Systems: Reviews the performance of low-cost MRI control systems across multiple sites. Published in NMR in Biomedicine (2023).

Prepolarized MRI for Hard Tissues: Studies MRI techniques for imaging hard tissues and solid-state matter. Published in NMR in Biomedicine (2022).

Portable MRI Systems: Explores portable MRI systems for indoor, outdoor, and home use. Published in Scientific Reports (2022).

CNN for Noise Reduction in Low-field MRI: Proposes a convolutional neural network (CNN) for electromagnetic noise reduction in MRI applications. Published in IEEE Transactions on Medical Imaging (2022).

Magneto-stimulation in Rapid Field Dynamics: Examines magneto-stimulation limits in MRI applications involving rapid field changes. Published in Physics in Medicine and Biology (2022).

Fast 0.5 T Prepolarizer Module: Discusses a fast prepolarizer module for preclinical MRI applications. Published in IEEE Transactions on Magnetics (2022).

 

Conclusion

The candidate is an outstanding contender for the Best Researcher Award, with a proven track record of impactful research, leadership, and innovation in medical and quantum technologies. Their work addresses critical gaps in current medical imaging and quantum sensing technologies, with the potential to bring profound benefits to healthcare systems globally. With a well-rounded approach that blends research, commercialization, and education, they exemplify the qualities of an exceptional researcher. Further expansion into diverse medical applications and commercial scalability could elevate their contributions even further.

Pedro Villarego | Bio-Mechanics | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Pedro Villarego | Bio-Mechanics | Best Researcher Award

Associate Chief of Surgery at Fundación Jiménez Díaz University Hospital, Spain

Assoc Prof Dr. Pedro Villarego is an accomplished medical professional with over 21 years of specialized experience in surgery. He currently serves as the Associate Chief and coordinator of several surgical units at Fundación Jiménez Díaz University Hospital. 🩺 His expertise spans peritoneal oncologic surgery, hepatobiliary surgery, endocrine surgery, and breast pathology.  He earned his medical degree from the University of Córdoba and a Ph.D. in Medicine and Surgery from the University of Málaga. He has made significant contributions to cancer care, including the establishment of the first Intraperitoneal Chemohyperthermia Unit in Castilla-La Mancha.  Assoc Prof Dr. Pedro Villaregois also recognized for his teaching roles at the Autonomous University of Madrid and has supervised numerous doctoral theses.

Publication Profile

orcid

Education  🎓

Assoc Prof Dr. Pedro Villarego completed his Bachelor’s degree in Medicine at the University of Córdoba in 1995. 🩺 He later earned an Official Specialist Title in General Surgery and Digestive System from the 12 de Octubre University Hospital in 2004. 📚 His academic journey culminated with a Ph.D. in Medicine and Surgery from the University of Málaga in 2011, where he defended his doctoral thesis on VEGF and VEGFC levels in gastric cancer. 🎖️ Assoc Prof Dr. Pedro Villarego holds two master’s degrees: one in Medical Management and Clinical Management from UNED (2008-2009) and another in Sarcomas and Musculoskeletal Tumors from the European University of Madrid (2021-2022). 📖 His academic excellence is reflected in his outstanding Cum Laude honors and ongoing dedication to surgical research.

Experience 🏥 

Assoc Prof Dr. Pedro Villaregohas over two decades of specialized surgical experience. He secured a permanent statutory position at Castilla-La Mancha Health Service’s Ciudad Real University Hospital in 2008. 💼 Currently, he serves as the Associate Chief at Fundación Jiménez Díaz University Hospital, coordinating several high-profile units, including Peritoneal Oncologic Surgery and Hepatobiliary Surgery. 👩‍🏫 Since 2022, Dr. [Name] has been an Associate Professor at the Autonomous University of Madrid, where he teaches surgery and biomedical engineering. 📚 His teaching experience also extends to the University of Castilla-La Mancha, where he served from 2013 to 2018. 🎓 He has supervised 5 doctoral theses and 8 undergraduate projects, contributing extensively to surgical education and research.

Awards and Honors 🏅

Assoc Prof Dr. Pedro Villarego has been the recipient of several prestigious awards. In 2013, he received the gold badge of AMUMA for his pioneering work in ovarian cancer care and establishing the first Intraperitoneal Chemohyperthermia Unit in Castilla-La Mancha. 🌟 His dedication to research was recognized in 2020 when he won the National Research Intensification Award from the Quironsalud Group. 🏆 Assoc Prof Dr. Pedro Villarego has been honored for his innovative contributions to cancer treatment, particularly in surgical oncology and multidisciplinary approaches to patient care. 🏅 His efforts have made a significant impact on both clinical practices and surgical research in Spain, earning him national recognition. 📖 Additionally, his research in oncologic surgery has garnered awards for excellence in medical advancement.

Research Focus 🔬

Assoc Prof Dr. Pedro Villarego focuses his research on surgical oncology, particularly peritoneal oncologic surgery and the role of VEGF/VEGFC in gastric cancer recurrence and mortality. 💉 He is dedicated to improving outcomes for cancer patients through innovations in fiber optic sensing, hyperthermic intraperitoneal chemotherapy (HIPEC), and minimally invasive surgical techniques. 🩺 His research also explores hepatobiliary and endocrine surgery, as well as breast pathology, aiming to integrate advanced technologies into surgical practices. 📚 Assoc Prof Dr. Pedro Villarego has contributed to over 15 national and provincial projects and holds multiple patents in his field. 📖 His work extends to international collaborations on cancer treatment protocols and he is particularly interested in translational research that bridges clinical applications with scientific discovery.

Publication  Top Notes

Intraperitoneal administration of carcinoembryonic antigen-directed CAR T cells for peritoneal carcinomatosis in colorectal cancer – Cytotherapy (2024)【DOI: 10.1016/J.JCYT.2023.10.007】.

Paclitaxel as HIPEC drug for ovarian peritoneal metastases – Current Oncology (2024)【DOI: 10.3390/CURRONCOL31020048】.

POTEE induces invadopodia formation in breast cancer cells – Molecular Oncology (2024)【DOI: 10.1002/1878-0261.13568】.

Non-invasive estimation of PCI in colorectal peritoneal carcinomatosis – Cirugía Española (2024)【DOI: 10.1016/J.CIRENG.2022.03.021】.

Long-term intraperitoneal access with new catheter design – Journal of Surgical Oncology (2024)【DOI: 10.1002/jso.27843】.

Pseudomyxoma peritonei: No systemic dissemination with undetectable ctDNA – European Journal of Surgical Oncology (2024)【DOI: 10.1016/j.ejso.2024.108395】.

Efficacy and safety of HIPEC in colon cancer – JAMA Surgery (2023)【DOI: 10.1001/JAMASURG.2023.0662】.

First trial of CEB-01 for retroperitoneal sarcoma – Annals of Oncology (2023)【DOI: 10.1016/J.ANNONC.2023.09.1161】.

Adipose-derived mesenchymal stem cells in abdominal sepsis – Stem Cell Research & Therapy (2023)【DOI: 10.1186/S13287-023-03588-X】.

Mucin analysis in pseudomyxoma peritonei – Journal of Clinical Medicine (2023)【DOI: 10.3390/JCM12124007】.

Conclusion

Given the individual’s significant contributions to the fields of surgical oncology, clinical management, research, and education, they are a highly deserving candidate for the Best Researcher Award. Their achievements in establishing innovative cancer treatment methods, combined with their leadership in both medical practice and academic spheres, highlight their outstanding qualifications. Expanding their international research presence and publication record could further enhance their already impressive profile for future recognition.